This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Drimia maritima
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
Bulbous Mediterranean plant of coastal areas; bulb used in historical medicine as cardiac glycoside source and expectorant; related to digitalis.
Bulbous Mediterranean plant of coastal areas; bulb used in historical medicine as cardiac glycoside source and expectorant; related to digitalis. Key active compounds include scillaren A, scillaren B, proscillaridin A.
scillaren A, along with scillaren B and proscillaridin A, are the primary bioactive compounds in Scilla Squill. The specific pharmacological pathways require further study, though traditional use supports its efficacy.
Cardiotonic glycoside source
Supported by clinical evidence; more large-scale trials would strengthen findings
Expectorant
Supported by clinical evidence; more large-scale trials would strengthen findings
Historical pharmaceutical reference
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Cardiac insufficiency in historical European medicine
Based on traditional use; clinical evidence limited
Expectorant for coughs
Based on traditional use; clinical evidence limited
Used since ancient Egyptian medicine for heart conditions
Based on traditional use; clinical evidence limited
Rodenticide (red squill variety)
Based on traditional use; clinical evidence limited
Found an error or have a correction for Scilla Squill?
Report an Issue →